Posted inNews
OpenAI Buys Orchestra Bio to Expand Drug-Development AI
OpenAI has acquired Orchestra Bio, a four-year-old startup building AI agents for pharmaceutical drug development, absorbing its team and technology into the company's Rosalind life-sciences unit. The deal was announced…
